Source: Cannara Biotech Inc.
  • Cannara Biotech (LOVE) has entered British Columbia’s marketplace and has launched its first two premium products in the vape and accessory categories
  • The BC Liquor Distribution Branch has listed seven SKUs across Tribal, Nugz, and Orchid CBD
  • This month, the company also launched its first live resin vape cartridge, Tribal G Mint, in Ontario, as well as premium universal 510 vape battery, the Tribal UNI Pro ARK, across Canada
  • Cannara Biotech (LOVE) opened trading at $0.115 per share

Cannara Biotech (LOVE) has entered British Columbia’s marketplace and has launched its first two premium products in the vape and accessory categories.

Cannara’s President and Chief Executive Officer, Zohar Krivorot, stated that the BC Liquor Distribution Branch has shown great confidence in the company’s value proposition by listing seven SKUs across Tribal, Nugz, and Orchid CBD.

“We couldn’t be happier to see our flower, pre-roll, and hash concentrates ship to British Columbia retailers and consumers this week, and we thank our dedicated team that has overseen the growth and expansion across three of Canada’s largest markets, Ontario, Quebec, and British Columbia, in addition to Saskatchewan.”

Source: Cannara Biotech Inc.

This month, the company also launched its first live resin vape cartridge, Tribal G Mint, in Ontario, as well as premium universal 510 vape battery, the Tribal UNI Pro ARK, across Canada.

Cannara Biotech Inc. is a producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. Cannara owns two Quebec -based mega facilities spanning over 1,650,000 sq. ft., providing the Company with 125,000 kg of potential annualized cultivation output.

Cannara Biotech (LOVE) opened trading at $0.115 per share.


More From The Market Online

Odd Burger to add 40 locations in Florida

Odd Burger (TSXV:ODD) will develop 40 new locations in Florida over the next eight years, with its sights set on further U.S. expansion.

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.